Assignee
ESPERION THERAPEUTICS INC
US·51 granted patents·23 pending applications·1,684 citations·filing 1997–2024
Top patents by PatentIndex Score
74 records- 0199US6506799B1Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compoundsESPERION THERAPEUTICS INC·Filed 2000·Granted Jan 14, 2003·158 cites·27 claims
- 0298US9624152B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·17 cites·14 claims
- 0398US9452964B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2015·Granted Sep 27, 2016·22 cites·20 claims
- 0497US10118881B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2017·Granted Nov 6, 2018·14 cites·21 claims
- 0597US7576130B2Dihydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2007·Granted Aug 18, 2009·30 cites·5 claims
- 0697US7405226B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2006·Granted Jul 29, 2008·38 cites·12 claims
- 0797US6459003B1Ether compoundsESPERION THERAPEUTICS INC·Filed 2000·Granted Oct 1, 2002·80 cites·7 claims
- 0897US6410802B1Methods for synthesizing ether compounds and intermediates thereforESPERION THERAPEUTICS INC·Filed 2000·Granted Jun 25, 2002·81 cites·5 claims
- 0996US10941095B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2018·Granted Mar 9, 2021·3 cites·24 claims
- 1096US10047028B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2016·Granted Aug 14, 2018·12 cites·9 claims
- 1196US9006290B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2013·Granted Apr 14, 2015·17 cites·10 claims
- 1296US8623915B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2012·Granted Jan 7, 2014·20 cites·20 claims
- 1396US7838554B2Dihydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2009·Granted Nov 23, 2010·21 cites·13 claims
- 1496US7812199B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2007·Granted Oct 12, 2010·24 cites·26 claims
- 1596US7335799B2Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2003·Granted Feb 26, 2008·49 cites·18 claims
- 1696US6831105B2Compositions comprising ether compounds and pharmaceutical uses thereforESPERION THERAPEUTICS INC·Filed 2002·Granted Dec 14, 2004·48 cites·17 claims
- 1796US6680203B2Fourier transform mass spectrometry of complex biological samplesESPERION THERAPEUTICS INC·Filed 2000·Granted Jan 20, 2004·146 cites·32 claims
- 1896US6646170B2Intermediates for the synthesis of ether compoundsESPERION THERAPEUTICS INC·Filed 2002·Granted Nov 11, 2003·51 cites·2 claims
- 1995US7119221B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2003·Granted Oct 10, 2006·32 cites·6 claims
- 2095US6790953B2Ether compoundsESPERION THERAPEUTICS INC·Filed 2002·Granted Sep 14, 2004·52 cites·1 claims
- 2195US6703422B2Sulfide and disulfide compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2001·Granted Mar 9, 2004·90 cites·16 claims
- 2295US6673780B2Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·88 cites·9 claims
- 2394US7335689B2Dihydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2003·Granted Feb 26, 2008·27 cites·31 claims
- 2494US7192940B2Ether compoundsESPERION THERAPEUTICS INC·Filed 2004·Granted Mar 20, 2007·37 cites·3 claims
- 2594US6909014B2Intermediates for the synthesis of ether compoundsESPERION THERAPEUTICS INC·Filed 2003·Granted Jun 21, 2005·35 cites·1 claims
- 2694US6699910B2Ketone compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2001·Granted Mar 2, 2004·77 cites·17 claims
- 2792US7304093B2Ketone compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2003·Granted Dec 4, 2007·34 cites·25 claims
- 2892US6713507B2Ether compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2001·Granted Mar 30, 2004·52 cites·19 claims
- 2991US6423830B1Process for purifying apolipoprotein A or apolipoprotein EESPERION THERAPEUTICS INC·Filed 2000·Granted Jul 23, 2002·39 cites·7 claims
- 3091US6329341B1Method of treating septic shockESPERION THERAPEUTICS INC·Filed 1999·Granted Dec 11, 2001·61 cites·21 claims
- 3190US12398087B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2024·Granted Aug 26, 2025·0 cites·17 claims
- 3289US2024286987A1Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3388US12404227B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2023·Granted Sep 2, 2025·0 cites·20 claims
- 3488US11407705B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2021·Granted Aug 9, 2022·1 cites·20 claims
- 3587US2023210800A1Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3686US11926584B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2023·Granted Mar 12, 2024·0 cites·20 claims
- 3785US2020189999A1Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3884US6617134B1Dimer of molecular variant of apolipoprotein and processes for the production thereofESPERION THERAPEUTICS INC·Filed 1999·Granted Sep 9, 2003·56 cites·18 claims
- 3983US11987548B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2022·Granted May 21, 2024·0 cites·20 claims
- 4082US11744816B2Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·1 cites·8 claims
- 4182US11613511B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2022·Granted Mar 28, 2023·0 cites·17 claims
- 4282US11116739B2Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2016·Granted Sep 14, 2021·2 cites·1 claims
- 4382US8975300B2Ketone compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2013·Granted Mar 10, 2015·3 cites·8 claims
- 4482US6953840B2Methods of using non-human animal Apolipoprotein A-I proteinESPERION THERAPEUTICS INC·Filed 2003·Granted Oct 11, 2005·21 cites·33 claims
- 4582US6090921AProcess for purifying apolipoprotein a or apolipoprotein eESPERION THERAPEUTICS INC·Filed 1997·Granted Jul 18, 2000·45 cites·24 claims
- 4682US2021395175A1Hydroxyl compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4781US11760714B2Methods of making bempedoic acid and compositions of the sameESPERION THERAPEUTICS INC·Filed 2022·Granted Sep 19, 2023·0 cites·20 claims
- 4880US2025064767A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4976US2024148681A1Fixed dose combinations and formulations comprising etc1002 and one or more statins and methods of treating or reducing the risk of cardiovascular diseaseESPERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 5075US6559284B1Process for purifying a proteinESPERION THERAPEUTICS INC·Filed 1997·Granted May 6, 2003·30 cites·4 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ESPERION THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →